-- China's drug regulator approved Chengdu Easton Biopharmaceuticals' (SHA:688513) acetaminophen/oxycodone extended-release tablets, according to a Thursday disclosure to the Shanghai Stock Exchange.
The drug is indicated for moderate to severe post-operative pain.